Dispatch: Cycling & EPO | Outside Online

You Are Here:

Home >> Spinning in Their Graves (Cont.)

Today's Question
What should you do if you run into a cougar in the backcountry? answer

What is the number one backcountry skill people should learn? answer

Today's Question
What are the five best environmental movies of all time? answer

What are the greenest colleges? answer

What kind of dog will make me look manlier? answer
Is there a sport that safely combines my twin passions for guns and kayaks? answer
How come most of the world's cultures enjoy eating goat, but Americans don't? answer

Online Favorites

Special Issues

Photo Galleries

Outside Magazine June 2004

Page:

Spinning in Their Graves (Cont.)

UNFORTUNATELY, AUTOPSIES can only show that a heart attack occurred, not that EPO caused it or was even present in the bloodstream at the time of death. Thus cycling remains where it's been for decades: under a cloud, with little proof about who's cheating, who isn't, and what the fallout may be for the long-term health of riders.

There are just as many cyclists using drugs now as ever before, says one expert—and for the first time, a U.S. rider has been suspended for taking EPO.

If that conundrum sounds familiar, it should. Cycling endured a drug-related mega-scandal back in 1998, when the entire Festina team was kicked out of the Tour de France after an employee was busted with a carload of EPO and other banned substances. No knowledgeable observer thinks the sport has completely cleaned up since then.

"There are just as many cyclists using drugs now as ever before," insists Yesalis. "Do I know enough to prove they're cheating in a court of law? No. But I don't believe you can win the Tour de France clean."

In the United States, the deaths of Pantani and Sermon didn't get much play, but other drug scandals have. Major League Baseball is grappling with an ongoing grand-jury investigation into BALCO, a San Francisco–area sports lab accused of providing steroids and human growth hormone to track athletes and pro baseball players, including superstars Barry Bonds and Jason Giambi. The heatstroke that in 2003 killed Baltimore Orioles pitcher Steve Bechler, 23, was linked to his use of the diet pill ephedra. In March, track cyclist Adham Sbeih, 30, an Olympic hopeful from Sacramento, California, received the first suspension ever issued to a U.S. athlete for using EPO.

With a potentially historic Tour around the bend, the current dustup over cyclists and doping warranted a response from Lance Armstrong himself. He has repeatedly, vehemently, and convincingly denied that any of his five consecutive Tour wins were drug-fueled, but the aspersions cast upon the Tour have, understandably if not justifiably, directed a new volley of questions toward the reigning champ, prompting Armstrong to write an open letter to the press.

"I am the most tested athlete on this planet," he reiterated. "I have never had a single positive test result, and I do not take performance enhancing drugs."

Still, uncertainty shadows both the innocent and the guilty: It is simply too easy to avoid getting caught. EPO has been in the peloton since the eighties, but it was undetectable in drug screens until 2000. Current tests work only if administered within six days of EPO use—performance benefits can remain for up to six weeks—so authorities look for indirect clues like an elevated hematocrit, a figure determined by the percentage of red cells in the bloodstream.

Healthy adult males have a hematocrit of up to 46 percent. To avoid busting athletes with a naturally high count, the Switzerland-based Union CycIiste Inter-nationale (UCI)—cycling's governing body—set the acceptable level at 50. But anyone with a wallet-size centrifuge, hypodermic needle, and blood-thinning solutions can easily tweak down to a perfectly legal 49.9 percent in minutes.

So far, the most concerted effort to place controls on doping has come from the World Anti-Doping Agency (WADA), an independent outfit created in the wake of the Tour's 1998 meltdown that works with Olympic officials and public authorities to establish drug-monitoring standards. In March 2003, WADA finalized the World Anti-Doping Code, which mandates stiff two-year suspensions for athletes who use banned substances.

Unfortunately, the UCI, perhaps fearing that such a crackdown could damage its stars, has yet to sign on, making cycling one of five Olympic sports that, as of press time, hadn't accepted the code. Failure to adopt could keep cyclists out of this summer's Games.

Meanwhile, athlete testimony and insider tell-alls continue to surface, further battering cycling's troubled image. Philippe Gaumont, a Cofidis pro who was busted in February for using EPO, told reporters he believes that 95 percent of Tour riders are still doping. Late in March, allegations arose about organized drug use on Spain's Kelme team, killing the squad's Tour de France hopes.

It may be impossible to ever know the true pervasiveness of the problem, or the guilt or innocence of riders. Further, gene doping, a science that would render current tests irrelevant, looms on the horizon. Throw in an event like the Tour de France—and the dollars at stake—and an immensely challenging picture emerges.

"It's an elephant," sighs Dick Pound, president of WADA. "There are very heavily entrenched entities in this, and a lot of economics involved."

The two realities of the Tour—its enormous popularity and the specter of corruption—persist side by side. "If there was a large boycott—no one watching on TV, no one cheering along the side of the road—then maybe things would change," says Yesalis. "But I don't think the fans really care."

Page:

•	Subscribe to Outside and get a FREE Gift!

•	Give the gift of Outside Magazine!

•	Subscribe to Outside Online's free weekly e-mail newsletter featuring gear reviews, fitness advice, galleries, podcasts, and more.